Drug Offers Millions Hope for Endometriosis Treatment

Nearly 28 million women suffer from painful uterine fibroids and a related condition called endometriosis. But one drug is bringing new hope to those who have endured this excruciating pain.

Caitlin Weingrove is an elementary school teacher who hopes to have children of her own one day.

“When teaching first grade, it’s very important to move quickly and show up with energy every day,” said Weingrove.

But with each menstrual period, Ms. Winegrove was depressed by the pain of fibroids and endometriosis.

“I’ve been suffering from period cramps and severe cramps.”

Uterine fibroids are noncancerous stalk-like tumors in the uterus. In endometriosis, tissue grows outside the uterus.

“When people have fibroid pain, they feel very heavy and the pressure that comes with it,” says Latasha Murphy, M.D., a gynecological surgeon at Mercy Medical System in Baltimore, Maryland. “In the case of endometriosis pain, it is commonly described as a burning or stabbing sensation.”

Murphy performed a minimally invasive laparoscopy on Wingglove, which revealed 10 fibroids and other fibroids.

“For her endometriosis, we were able to remove it from about four different locations in her pelvis,” Murphy said.

After surgery, Murphy prescribed a new FDA-approved drug called Myfenbry.

“The message from the brain to the ovaries to produce estrogen is reduced,” Murphy says. “Estrogen stimulates the growth of endometriosis and fibroids.”

For Kaitlyn Weingrove, it was a lifesaver.

“I haven’t actually had any cramps,” said Weingrove. “Since I started taking it, my periods have become much lighter.”

Myfembree has been approved by the FDA in mid-2022. In addition to treating uterine fibroids and endometriosis, the drug also works as an alternative to oral contraceptives.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *